Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company
CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on http://www.nasdaq.com and on the seven-story NASDAQ tower, the largest stationary video screen in the world.
NASDAQ Opening Bell Ceremony - Webcam Instructions
To view the NASDAQ Opening Bell ceremony, go to http://www.kendle.com or http://www.nasdaq.com/about/marketsitetowervideo.asx. Please note:
-- Viewers must have Windows Media Player to view the webcam (Windows
Media Player is downloadable at no charge from
-- It is recommended viewers download the webcam at 9:15 a.m. so there is
time to troubleshoot in the event of technical difficulties
-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the
router will be switched and viewers will see inside the MarketSite
studio where the ceremony will take place
-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is
dependent on Internet hook up.
NASDAQ Opening Bell Ceremony - Satellite Feed Information
The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.
Copyright©2007 PR Newswire.